Retatrutide vs Tirzepatide: Obesity Study Nears Completion | Retatrutide News

Eli Lilly is conducting a study to compare retatrutide and tirzepatide in adults with obesity. The study will last about 89 weeks and is currently not r...
Clinical Trials · October 16, 2026